MX2016000308A - Beta-casein a2 and reducing or preventing symptoms of lactose intolerance. - Google Patents
Beta-casein a2 and reducing or preventing symptoms of lactose intolerance.Info
- Publication number
- MX2016000308A MX2016000308A MX2016000308A MX2016000308A MX2016000308A MX 2016000308 A MX2016000308 A MX 2016000308A MX 2016000308 A MX2016000308 A MX 2016000308A MX 2016000308 A MX2016000308 A MX 2016000308A MX 2016000308 A MX2016000308 A MX 2016000308A
- Authority
- MX
- Mexico
- Prior art keywords
- casein
- beta
- reducing
- lactose intolerance
- preventing symptoms
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title abstract 4
- 108010076119 Caseins Proteins 0.000 title abstract 4
- 235000021247 β-casein Nutrition 0.000 title abstract 4
- 201000010538 Lactose Intolerance Diseases 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Preventing or reducing the symptoms of lactose intolerance in an animal comprising the consumption by the animal of a composition containing beta-casein, or providing the composition to the animal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361845480P | 2013-07-12 | 2013-07-12 | |
PCT/NZ2014/000141 WO2015005804A1 (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016000308A true MX2016000308A (en) | 2016-11-14 |
MX368912B MX368912B (en) | 2019-10-21 |
Family
ID=52280344
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016000308A MX368912B (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance. |
MX2019012446A MX2019012446A (en) | 2013-07-12 | 2016-01-08 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019012446A MX2019012446A (en) | 2013-07-12 | 2016-01-08 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance. |
Country Status (21)
Country | Link |
---|---|
US (3) | US20160136238A1 (en) |
EP (2) | EP3542805A1 (en) |
JP (2) | JP6436592B2 (en) |
KR (2) | KR102291660B1 (en) |
CN (3) | CN105431156A (en) |
AU (2) | AU2014287862B2 (en) |
BR (1) | BR112016000612B8 (en) |
CA (2) | CA2917492C (en) |
CL (1) | CL2016000064A1 (en) |
DK (1) | DK3019180T3 (en) |
ES (1) | ES2743194T3 (en) |
HK (1) | HK1223846A1 (en) |
IL (2) | IL243366B (en) |
MX (2) | MX368912B (en) |
MY (2) | MY172939A (en) |
NZ (2) | NZ715985A (en) |
PH (2) | PH12016500032B1 (en) |
RU (1) | RU2671562C2 (en) |
SG (2) | SG10201710237PA (en) |
WO (1) | WO2015005804A1 (en) |
ZA (1) | ZA201600007B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7137745B2 (en) * | 2015-05-22 | 2022-09-15 | ズィ・エイツー・ミルク・カンパニー・リミテッド | Beta casein A2 and antioxidant capacity |
WO2017003300A1 (en) * | 2015-06-29 | 2017-01-05 | The A2 Milk Company Limited | A2 beta-casein and viscosity of milk products |
RU2766194C2 (en) | 2016-03-30 | 2022-02-09 | Зе А2 Милк Компани Лимитед | Beta-casein and cognitive function |
CA3036494C (en) | 2016-09-30 | 2022-10-18 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
WO2021003741A1 (en) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | APPLICATION OF β-CASEIN A2 AND COMPOSITION THEREOF IN PROMOTING PROLIFERATION OF BIFIDOBACTERIUM |
CN112205476A (en) * | 2019-07-11 | 2021-01-12 | 北京三元食品股份有限公司 | Beta-casein A2 and application of composition thereof in promoting proliferation of bifidobacterium |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE442585T1 (en) | 1994-11-04 | 2009-09-15 | A2 Corp Ltd | SELECTION PROCESS FOR NON-DIABETOGENIC MILK OR MILK PRODUCTS AS WELL AS MILK OR MILK PRODUCTS COVERED HEREIN |
WO1996036239A1 (en) | 1995-05-16 | 1996-11-21 | Corran Norman Stuart Mclachlan | Food product and process |
US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
EP1196047A4 (en) * | 1999-06-29 | 2004-12-22 | New Zealand Milk Inst Ltd | Prophylactic dietary supplement based on milk |
AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
US20060280802A1 (en) * | 2002-10-04 | 2006-12-14 | Campbell Julie H | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
US8524225B2 (en) * | 2003-09-23 | 2013-09-03 | Dsm Ip Assets B.V. | Use of proline specific endoproteases to hydrolyse peptides and proteins |
CN1899054A (en) * | 2006-07-17 | 2007-01-24 | 颜贻谦 | Method for making sugar-removing milk |
AU2010233000A1 (en) * | 2009-04-03 | 2011-10-27 | Nestec S.A. | Milk-like beverages |
US9167824B2 (en) * | 2009-04-15 | 2015-10-27 | Glanbia Nutritionals (Ireland) Limited | Process for the preparation of a reduced lactose milk product |
DE102010009582A1 (en) * | 2010-02-05 | 2011-08-11 | Vitacare GmbH & Co. KG, 60318 | Agent for use in lactase deficiency and lactose intolerance |
CN103315063A (en) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | Infant formula milk powder capable of preventing diseases |
WO2015187795A1 (en) * | 2014-06-03 | 2015-12-10 | Abbott Laboratories | Nutritional compositions comprising a lipophilic active ingredient |
-
2014
- 2014-07-10 BR BR112016000612A patent/BR112016000612B8/en active IP Right Grant
- 2014-07-10 AU AU2014287862A patent/AU2014287862B2/en active Active
- 2014-07-10 KR KR1020207019514A patent/KR102291660B1/en active IP Right Grant
- 2014-07-10 KR KR1020167003267A patent/KR102367941B1/en active IP Right Grant
- 2014-07-10 JP JP2016525322A patent/JP6436592B2/en active Active
- 2014-07-10 CN CN201480039570.XA patent/CN105431156A/en active Pending
- 2014-07-10 MY MYPI2016700051A patent/MY172939A/en unknown
- 2014-07-10 DK DK14823628.4T patent/DK3019180T3/en active
- 2014-07-10 US US14/904,178 patent/US20160136238A1/en not_active Abandoned
- 2014-07-10 ES ES14823628T patent/ES2743194T3/en active Active
- 2014-07-10 CN CN201911100359.5A patent/CN110800803A/en active Pending
- 2014-07-10 RU RU2015156804A patent/RU2671562C2/en active
- 2014-07-10 CN CN202210552915.8A patent/CN114832092A/en active Pending
- 2014-07-10 NZ NZ715985A patent/NZ715985A/en unknown
- 2014-07-10 SG SG10201710237PA patent/SG10201710237PA/en unknown
- 2014-07-10 WO PCT/NZ2014/000141 patent/WO2015005804A1/en active Application Filing
- 2014-07-10 MY MYPI2019006591A patent/MY190309A/en unknown
- 2014-07-10 NZ NZ754642A patent/NZ754642A/en unknown
- 2014-07-10 CA CA2917492A patent/CA2917492C/en active Active
- 2014-07-10 EP EP19169651.7A patent/EP3542805A1/en active Pending
- 2014-07-10 MX MX2016000308A patent/MX368912B/en active IP Right Grant
- 2014-07-10 CA CA3214545A patent/CA3214545A1/en active Pending
- 2014-07-10 EP EP14823628.4A patent/EP3019180B1/en not_active Revoked
- 2014-07-10 SG SG11201510707YA patent/SG11201510707YA/en unknown
-
2015
- 2015-12-27 IL IL243366A patent/IL243366B/en active IP Right Grant
-
2016
- 2016-01-04 ZA ZA2016/00007A patent/ZA201600007B/en unknown
- 2016-01-05 PH PH12016500032A patent/PH12016500032B1/en unknown
- 2016-01-08 MX MX2019012446A patent/MX2019012446A/en unknown
- 2016-01-12 CL CL2016000064A patent/CL2016000064A1/en unknown
- 2016-10-25 HK HK16112270.8A patent/HK1223846A1/en unknown
-
2018
- 2018-08-13 IL IL261143A patent/IL261143B/en active IP Right Grant
- 2018-08-17 JP JP2018153472A patent/JP6990154B2/en active Active
-
2019
- 2019-05-27 AU AU2019203684A patent/AU2019203684B2/en active Active
- 2019-07-03 PH PH12019550112A patent/PH12019550112A1/en unknown
-
2020
- 2020-01-09 US US16/738,792 patent/US20200147173A1/en not_active Abandoned
-
2021
- 2021-12-21 US US17/557,343 patent/US20220175882A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019550112A1 (en) | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance | |
PH12019550096A1 (en) | Beta-casein a2 and prevention of inflammation of the bowel | |
MX365614B (en) | Compositions useful for treating disorders related to kit. | |
MX2020006720A (en) | Beta-casein a2 and blood glucose levels. | |
PH12016500798A1 (en) | Fungicidal composition and the use thereof | |
MY182845A (en) | Dual-bearing reel | |
CL2016001428A1 (en) | Use of a composition with cognitive exercises useful for the prevention or treatment of delayed cognitive development in children. | |
WO2015027160A3 (en) | Allosteric modulators of the cannibinoid 1 receptor | |
IN2014DN06617A (en) | ||
TWD160461S (en) | Electromagnetic valve | |
Al-Daghman | One of the indications of addition in the Quranic context Manifestations of the intention of the appointment and the ratio by adding the pronoun (ha) to the formula (verbs) in the light of appropriate knowledge | |
PL406123A1 (en) | The Internet Portal: Face to face | |
TWD176686S (en) | Gas control device | |
TH159417A (en) | A setable component consisting of wallastonite and pumice and method of application. | |
UA88327U (en) | Method for treating generalized periodontitis in diabetes mellitus type 2 | |
EA201991189A1 (en) | SGC STIMULANTS | |
TR201010571U (en) | Presentation and maintenance kit. | |
TR201900511T4 (en) | Method for the preparation of metallic dithiocarbamates. | |
PL405631A1 (en) | Dynamic feeder | |
UA98759U (en) | Method of typing of nanophotonic elements of active and intelligent packing | |
UA70225U (en) | Use of miramistin-containing composition for treating sore throat | |
UA85296U (en) | Dietetic supplement "hawthorn elixir" | |
FR2971123B1 (en) | GALACTOFRUCTOSE FOR ITS INTESTINAL TRANSIT REGULATOR EFFECT | |
UA56040U (en) | 1,3-dimethyl-7-n-chlorobenzene-8-n-bromobenzylidene hydrazinoxanthine exhibiting diuretic and anti-oxidant action | |
TWD160103S (en) | Eyeglass frames |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |